Rapid Move Following Outpatient Surgery: Safety and Patient Characteristics

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age15+
SponsorAlgemeen Ziekenhuis Maria Middelares

About this trial

A descriptive, retrospective cohort study will be conducted to gain insight in the safety of the Rapid Move. The trial will include a group of Rapid Move patients, who were transferred to the Rapid Move after their outpatient surgery and subsequently discharged home. The Rapid Move is a short-stay PACU where patients recover from anaesthesia, are continuously monitored, and prepared for discharge within an hour after surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 15 years or older;

Patients who went to the Rapid Move after their outpatient procedure. Eligible procedures are: gastroscopy, coloscopy, vasectomy, scrotal surgery, circumcision or other minor penile surgery, intravesical Botox, insertion or removal of eardrum tubes in adults, sinus irrigation in adults, sleep endoscopy, bronchoscopy, removal of osteosynthetic material in the lower leg and foot, and tooth extraction (including wisdom teeth) and upper-forearm orthopedic surgery (excluding prosthetic surgery).

Disqualifiers

Inpatients defined as a patient who is formally admitted (or "hospitalized") to an institution for treatment and/or care and stays for a minimum of one night in the hospital or other institution providing inpatient care;

Patients undergoing emergency procedures.

Trial population

This study will include an intervention group with all consecutive patients, aged 15 years or older, who went to the Rapid Move after their outpatient procedure between 1 December 2023 and 1 December 2024 in general hospital Maria Middelares, Ghent, Belgium (Rapid Move patients).

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Rapid Move

    Other intervention

    A short-stay PACU where patients recover from anaesthesia, are continuously monitored, and prepared for discharge within an hour after surgery.

Treatment groups

1,500 Participants
are divided into 1 treatment group
Group A: All patients undergoing an outpatient procedure eligible for the Rapid Move.1 intervention

Trial outcomes

Primary outcomes

1

30-day readmission

The 30-day readmission rate is defined as the number of patients with an unplanned emergency hospital readmission, including emergency department (ED) visits with or without hospital readmission, occurring between the time the patient is discharged from the hospital after their outpatient surgery (index hospital admission) and 30 days after the surgery. An admission to a non-acute care facility is not considered a readmission. A readmission must be clinically related to the index hospital admission. The term 'clinically related' is defined as meaning that the underlying reason for readmission is plausibly related to the care rendered during or immediately following a prior hospital admission. A clinically related readmission may have resulted from the process of care and treatment during the prior admission or from a lack of post-admission follow-up, rather than from events that occurred after the prior admission within a specified readmission time interval that are unrelated to the p

Time frame
Up to 30 days after hospital discharge.

Secondary outcomes

1

Complications

Readmission reason, classified using the International Classification for Diseases (ICD)-11.

Time frame
Up to 30 days after hospital discharge.
2

Length of Stay

The time between the arrival at the Rapid Move unit and the time of hospital discharge.

Time frame
Minutes, up to 4 hours.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: